menu search

Veracyte, inc. (vcyt) q1 2023 earnings call transcript

Veracyte, Inc. (NASDAQ:VCYT ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participa...

May 4, 2023, 10:43 pm

Incyte (incy) q1 earnings miss estimates, revenues up y/y

Incyte's (INCY) first-quarter 2023 earnings and revenues miss estimates due to higher patient deductibl...

May 2, 2023, 4:51 pm

Incyte (incy) q1 earnings and revenues miss estimates

Incyte (INCY) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate...

May 2, 2023, 9:54 am

Humacyte to present at the h.c. wainwright bioconnect investor conference at nasdaq

DURHAM, N.C., April 28, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biote...

April 28, 2023, 12:00 pm

Oncocyte to announce first quarter 2023 financial results

IRVINE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision dia...

April 27, 2023, 4:59 pm

cytek biosciences, inc. (ctkb) soars 13.4%: is further upside left in the stock?

cytek Biosciences, Inc. (CTKB) witnessed a jump in share price last session on above-average trading vo...

April 27, 2023, 4:34 am

Will jakafi sales drive a beat for incyte (incy) q1 earnings?

Incyte's (INCY) first-quarter 2023 earnings are likely to have gained from higher Jakafi sales and incr...

April 26, 2023, 12:11 pm

Vaxcyte announces closing of $575 million public offering including full exercise of underwriters’ option to purchase additional shares

SAN CARLOS, Calif., April 21, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage ...

April 21, 2023, 9:25 pm

Incyte (incy) opzelura gets ec nod for non-segmental vitiligo

Incyte (INCY) gets EC approval for Opzelura (cream formulation of ruxolitinib) for the treatment of non...

April 21, 2023, 2:26 pm

Vaxcyte announces pricing of $500 million public offering

SAN CARLOS, Calif., April 19, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage ...

April 19, 2023, 4:26 am

Vaxcyte (pcvx) up on pneumococcal conjugate vaccine data

Vaxcyte (PCVX) announces positive results from the mid-stage study of its 24-Valent pneumococcal conjug...

April 18, 2023, 2:28 pm

Still 50% upside to go, wall street is getting vaxcyte right

When SVB Securities analyst David Risinger reiterated his bullish opinion on Vaxcyte, Inc. (NASDAQ: PCV...

April 18, 2023, 8:36 am


Search within

Pages Search Results: